FRANKLIN BERGER - 17 Jun 2022 Form 4 Insider Report for Atea Pharmaceuticals, Inc. (AVIR)

Role
Director
Signature
/s/ Andrea Corcoran, as Attorney-in-Fact for Franklin M. Berger
Issuer symbol
AVIR
Transactions as of
17 Jun 2022
Transactions value $
$0
Form type
4
Filing time
21 Jun 2022, 19:48:40 UTC
Previous filing
17 Jun 2022
Next filing
01 Nov 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVIR Stock Option (Right to Buy) Award $0 +61.3K $0.00 61.3K 17 Jun 2022 Common Stock 61.3K $6.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable in twelve (12) equal monthly installments following June 17, 2022, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date.